Latest filing published 17 Apr 2026 for Vivoryon Therapeutics N.V.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
J. Neugebauer appears in our data through filings on Vivoryon Therapeutics N.V. shares, published by AFM. Between 24 June 2025 and 17 April 2026, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 3 purchases, and no sale. The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 1 purchase and no sales.
The record was last updated on 17 April 2026 with an open-market purchase in Vivoryon Therapeutics N.V. Source: insider filings from AFM. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations